Navigation Links
Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference

RESEARCH TRIANGLE PARK, N.C., May 6 /PRNewswire-FirstCall/ --Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) today announced that Lawrence D. Stern, chairman and chief executive officer of Talecris, will present at the Bank of America Merrill Lynch 2010 Health Care Conference at 2:20 p.m., Thursday, May 13, 2010, at The Grand Hyatt in New York, N.Y.

A live webcast of Talecris' presentation will be accessible through the investor relations section of the Talecris Web site, A replay of the webcast will be available until May 28, 2010, and can be accessed at the same Web address.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis.  For more information, please visit:

SOURCE Talecris Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Talecris Biotherapeutics to Report First Quarter 2010 Financial Results
2. Siemens/Talecris Win Best Partnership in the Outsourcing Excellence Awards
3. Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
4. The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
5. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
6. Oxygen Biotherapeutics, Inc. Outlines Plans for New Products During Investor Conference Presentation
7. Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors
8. Oxford BioTherapeutics Appoints Michael Moore as Chairman
9. Oxygen Biotherapeutics, Inc. Expands Board of Directors
10. New Oxygen Biotherapeutics, Inc. Investor Presentation Available on Company Website
11. Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... New York on Wednesday, December 2 at 9:30 ... president and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim ... provide a corporate overview. --> th Annual Oppenheimer ...
(Date:11/24/2015)... 2015  Clintrax Global, Inc., a worldwide provider of clinical research ... announced that the company has set a new quarterly earnings record ... quarter growth posted for Q3 of 2014 to Q3 of 2015. ... Mexico , with the establishment of an Asia-Pacific ... United Kingdom and Mexico ...
(Date:11/24/2015)... 24, 2015 --> ... report released by Transparency Market Research, the global non-invasive ... CAGR of 17.5% during the period between 2014 and ... Global Industry Analysis, Size, Volume, Share, Growth, Trends and ... testing market to reach a valuation of US$2.38 bn ...
Breaking Biology Technology:
(Date:10/26/2015)... India , October 26, 2015 ... --> adds ... 2015 to 2021 as well as ... 2015-2019 research reports to its collection ... . --> ...
(Date:10/23/2015)... Oct. 23, 2015 Research and Markets ( ... "Global Voice Recognition Biometrics Market 2015-2019" report to ... --> The global voice recognition biometrics market to ... --> --> The ... prepared based on an in-depth market analysis with inputs ...
(Date:10/22/2015)... 2015  Synaptics (NASDAQ: SYNA ), a leading developer of ... ended September 30, 2015. --> ... grew 66 percent over the comparable quarter last year to $470.0 ... $23.8 million, or $0.62 per diluted share. ... quarter of fiscal 2016 grew 39 percent over the prior year ...
Breaking Biology News(10 mins):